| Symbol | TNDM |
|---|---|
| Name | TANDEM DIABETES CARE INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 12400 HIGH BLUFF DRIVE, San Diego, CA 92130 |
| Telephone | 858-366-6900 |
| Fax | — |
| — | |
| Website | https://www.tandemdiabetes.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001438133 |
| Description | Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a users pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States. Additional info from NASDAQ: |
2026-08-18 20:28
Vosseller Leigh 🟡 adjusted position in 1.5K shares (2 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.72 Transaction Date: Aug 15, 2026 | Filing ID: 000132
Read more
2026-08-18 20:28
Director Sheridan John F 🟡 adjusted position in 8.1K shares (2 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.72 Transaction Date: Aug 15, 2026 | Filing ID: 000131
Read more
2026-08-18 20:28
Morrison Susan 🟡 adjusted position in 809 shares (2 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.72 Transaction Date: Aug 15, 2026 | Filing ID: 000130
Read more
2026-08-18 20:27
Kyrillos Jean-Claude 🟡 adjusted position in 535 shares (1 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.72 Transaction Date: Aug 15, 2026 | Filing ID: 000129
Read more
2026-08-18 20:27
Gasser Elizabeth Anne 🟡 adjusted position in 1.6K shares (2 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.72 Transaction Date: Aug 15, 2026 | Filing ID: 000128
Read more
2026-08-18 20:23
📋 MARK NOVARA (Officer) plans to sell 131 shares of Tandem Diabetes Care, Inc. (at $22.25 each, total $3K) Filed: Aug 18, 2026 | ID: 008325
Read more
2026-07-17 20:07
Kyrillos Jean-Claude 🟡 adjusted position in 1.9K shares (1 derivative) of TANDEM DIABETES CARE INC (TNDM) at $15.28 Transaction Date: Jul 15, 2026 | Filing ID: 000116
Read more
2026-07-01 12:30
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
Read more
2026-06-30 12:30
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07507708 | Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Contro… | Na | Type 1 Diabetes (T1D) | Recruiting | 2026-05-14 | 2026-12-31 | ClinicalTrials.gov |
| NCT07517770 | Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existin… | Na | Type 1 Diabetes Mellitis | Not_Yet_Recruiting | 2026-05-01 | 2027-04-30 | ClinicalTrials.gov |
| NCT07211126 | The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 … | — | Diabetes Mellitus, Type 1 | Recruiting | 2026-03-03 | 2027-12-01 | ClinicalTrials.gov |
| NCT07325461 | Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use… | Na | Diabetes Mellitus, Type 1 | Completed | 2026-02-18 | 2026-06-24 | ClinicalTrials.gov |
| NCT07039617 | A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery … | Na | Type 1 Diabetes | Recruiting | 2025-09-02 | 2026-07-31 | ClinicalTrials.gov |
| NCT07020936 | AIDANET Pediatrics | Na | Type 1 Diabetes | Active_Not_Recruiting | 2025-07-21 | 2026-10-31 | ClinicalTrials.gov |
| NCT06880835 | Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypog… | Na | Diabetes Mellitus, Type 1 | Recruiting | 2025-06-05 | 2026-12-31 | ClinicalTrials.gov |
| NCT06834568 | Tandem Freedom - Feasibility Trial 2 | Na | Diabetes Mellitus, Type 1 | Completed | 2025-03-24 | 2025-04-07 | ClinicalTrials.gov |
| NCT06717451 | PS230005 Control-IQ 1.5 Post-Approval Study | — | Type 1 Diabetes | Completed | 2025-01-30 | 2026-08-10 | ClinicalTrials.gov |
| NCT06633965 | Safety and Feasibility Testing of a Smaller Network Version of AIDANET | Na | Type 1 Diabetes | Completed | 2024-11-20 | 2024-12-18 | ClinicalTrials.gov |
| NCT05973422 | Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 D… | Na | Type 1 Diabetes | Unknown | 2024-05-31 | 2024-09-30 | ClinicalTrials.gov |
| NCT06428591 | Tandem Freedom Feasibility Study 1 | Na | Diabetes Mellitus, Type 1 | Completed | 2024-05-29 | 2024-06-10 | ClinicalTrials.gov |
| NCT06273124 | Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabet… | Na | Type1diabetes | Completed | 2024-03-07 | 2024-12-11 | ClinicalTrials.gov |
| NCT05785832 | A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diab… | Na | Type 2 Diabetes Treated With Insulin | Completed | 2023-06-01 | 2024-09-24 | ClinicalTrials.gov |
| NCT05683392 | Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Typ… | Na | Type 1 Diabetes | Completed | 2023-02-01 | 2023-12-13 | ClinicalTrials.gov |
| NCT05610111 | Adaptive Biobehavioral Control (ABC) in a Closed-Loop System | Na | Type 1 Diabetes | Completed | 2023-01-18 | 2024-09-28 | ClinicalTrials.gov |
| NCT05403502 | Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With t… | Na | Type 1 Diabetes | Completed | 2022-08-31 | 2023-08-02 | ClinicalTrials.gov |
| NCT05422053 | Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) | Na | Type 1 Diabetes | Completed | 2022-06-29 | 2023-01-06 | ClinicalTrials.gov |
| NCT05204134 | Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID U… | Na | Type 1 Diabetes | Completed | 2022-03-24 | 2022-09-29 | ClinicalTrials.gov |
| NCT05111301 | Control-IQ Technology in Individuals With Type 2 Diabetes | Na | Type 2 Diabetes Treated With Insulin | Completed | 2021-11-30 | 2022-08-18 | ClinicalTrials.gov |
| NCT05014789 | Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study | Na | Diabetes Mellitus, Type 1 | Completed | 2021-08-19 | 2021-12-20 | ClinicalTrials.gov |
| NCT04614168 | Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in… | Na | Type 1 Diabetes | Completed | 2021-07-26 | 2025-12-26 | ClinicalTrials.gov |
| NCT04807374 | Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes | Na | Type 1 Diabetes | Completed | 2021-06-01 | 2023-06-22 | ClinicalTrials.gov |
| NCT04796779 | The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in You… | Na | Type 1 Diabetes | Completed | 2021-04-21 | 2022-07-31 | ClinicalTrials.gov |
| NCT04838561 | Assessing the Impact of Control-IQ Technology | — | Type 1 Diabetes | Completed | 2021-03-15 | 2021-10-26 | ClinicalTrials.gov |
| NCT04439903 | Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellit… | Na | Type 1 Diabetes | Completed | 2020-10-12 | 2021-02-22 | ClinicalTrials.gov |
| NCT04503174 | Control-IQ Observational (CLIO) Post-Approval Study | — | Diabetes Mellitus, Type 1 | Completed | 2020-08-04 | 2023-06-26 | ClinicalTrials.gov |
| NCT04266379 | Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia | Na | Type 1 Diabetes Mellitus With Hypoglycemia | Unknown | 2020-05-13 | 2023-02-03 | ClinicalTrials.gov |
| NCT03844789 | A Study of t:Slim X2 With Control-IQ Technology | Na | Type 1 Diabetes Mellitus | Completed | 2019-06-06 | 2020-03-20 | ClinicalTrials.gov |
| NCT03591354 | The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the… | Na | Type 1 Diabetes Mellitus | Completed | 2019-01-17 | 2020-03-09 | ClinicalTrials.gov |
| NCT03804983 | Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System U… | Na | Type 1 Diabetes Mellitus | Completed | 2019-01-15 | 2019-02-16 | ClinicalTrials.gov |
| NCT03563313 | The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the… | Na | Type 1 Diabetes Mellitus | Completed | 2018-06-28 | 2019-04-08 | ClinicalTrials.gov |
| NCT03369067 | Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp | Na | Type 1 Diabetes Mellitus | Completed | 2017-12-18 | 2018-04-15 | ClinicalTrials.gov |
| NCT03368937 | A Pilot Test of t:Slim X2 With Control-IQ Technology | Na | Type1 Diabetes Mellitus | Completed | 2017-12-08 | 2017-12-11 | ClinicalTrials.gov |
| NCT03195140 | Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial | Na | Diabetes Mellitus, Type 1 | Completed | 2017-08-11 | 2018-02-06 | ClinicalTrials.gov |
| NCT02844517 | International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol | Na | Diabetes Mellitus, Type 1 | Completed | 2016-11-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02877771 | Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study | Phase1 | Diabetes Mellitus | Completed | 2016-08-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02679287 | Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Clo… | Na | Diabetes Mellitus, Type 1 | Completed | 2016-02-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT01142895 | Validation Study of G4 User Interface | — | Diabetes Mellitus | Completed | 2010-05-01 | — | ClinicalTrials.gov |
Total clinical trials: 39
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Control-IQ Technology v1.5 | Other | Preclinical | Type 1 Diabetes | COMPLETED | NCT06717451 |
| SteadiSet Infusion Set | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT07325461 |
| Control IQ + sleep or exercise activity with TI | Other | Approved | Diabetes Mellitus, Type 1 | RECRUITING | NCT06880835 |
| CLC + ABC | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| CLC + BAM | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| Control-IQ technology 2.0 | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT05014789 |
| AIDANET + Anticipatory Closed Loop (ACL) | Other | Approved | Type 1 Diabetes (T1D) | RECRUITING | NCT07507708 |
| AIDANET + Fully Closed Loop (FCL) | Other | Approved | Type 1 Diabetes (T1D) | RECRUITING | NCT07507708 |
| Automated Insulin Delivery (AID) | Other | Approved | Type 1 Diabetes (T1D) | RECRUITING | NCT07507708 |
| SteadiSet Infusion Set | Other | Approved | Diabetes Mellitus, Type 1 | ACTIVE_NOT_RECRUITING | NCT07325461 |
| Tight Glycemia Goal | Other | Approved | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT07020936 |
| Normal Glycemia Goal | Other | Approved | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT07020936 |
| Control-IQ technology 2.0 | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT05014789 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| t:slim X2 pump with Control-IQ technology | Other | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT04503174 |
| SIGI Insulin Management System | Other | Approved | Type 1 Diabetes | UNKNOWN | NCT05973422 |
| CLC + ABC | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| CLC + BAM | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| AIDANET | Other | Approved | Type 1 Diabetes | COMPLETED | NCT06633965 |
| t:slim insulin pump with predictive low glucose suspend | Other | Phase PHASE1 | Diabetes Mellitus | COMPLETED | NCT02877771 |
| Artificial Pancreas | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02844517 |
| Sensor-augmented pump (SAP) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03563313 |
| t:slim X2 with Control-IQ Technology & Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03563313 |
| CLC | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02679287 |
| Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring | Other | Approved | Type 1 Diabetes Mellitus With Hypoglycemia | UNKNOWN | NCT04266379 |
| Closed-loop insulin infusion driven by continuous glucose monitoring through an algorithm, in free-life conditions | Other | Approved | Type 1 Diabetes Mellitus With Hypoglycemia | UNKNOWN | NCT04266379 |
| Control-IQ technology 2.0 | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT05014789 |
| Tandem t:slim X2 with Control-IQ Technology | Other | Approved | Type1 Diabetes Mellitus | COMPLETED | NCT03368937 |
| t:slim X2 with Basal-IQ & Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03591354 |
| t:slim X2 with Control-IQ Technology & Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03591354 |
| Control Group | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03844789 |
| t:slim X2 with Control-IQ Technology & Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03844789 |
| Tandem t:slim X2 with Control-IQ Technology V1.5 | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Standard Care (SC) | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Tandem t:slim X2 with Control-IQ Technology Pro | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Control IQ | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04807374 |
| Predictive Low Glucose Suspend | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03195140 |
| Control-IQ technology 1.5 | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05111301 |
| Automated Insulin Delivery Settings Initialization and Adaptation Algorithm | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05204134 |
| t:slim X2 insulin pump with Control-IQ technology 1.5 | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05403502 |
| Control-IQ with MyTDI | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03804983 |
| Hybrid Closed Loop (HCL) | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03804983 |
| Continuous Subcutaneous Insulin Infusion | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Dexcom CGM G5 | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Web-based Simulation Tool | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04439903 |
| t:slim X2 insulin pump with Control-IQ technology 2.0 | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05683392 |
| t:slim X2 insulin pump with Control-IQ technology 1.5 | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05422053 |
| SteadiSet Extended Wear Infusion Set | Other | Approved | Type1diabetes | COMPLETED | NCT06273124 |
| Control-IQ Technology v1.5 | Other | Preclinical | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06717451 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06428591 |
| Tight Glycemia Goal | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07020936 |
| Normal Glycemia Goal | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07020936 |
| Stable isotope studies- D2 Glucose and D5 Glycerol | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Blinded continuous glucose monitor | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Low carbohydrate diet | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Continuous glucose monitor | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Insulin pump | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Stepped hyperinsulinaemic-hypoglycaemic clamp study | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| Standard Therapy plus continuous glucose monitoring (CGM) | Drug | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | Other | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| SteadiSet Infusion Set | Other | Approved | Diabetes Mellitus, Type 1 | RECRUITING | NCT07325461 |
| Automated Insulin Delivery (AID) (usual care) | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET in FCL-HCL-mixed mode | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET + HCL | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET + FCL | Other | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | Other | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| AIDANET AI x 4 weeks | DEVICE | Approved | Type 1 Diabetes Mellitis | NOT_YET_RECRUITING | NCT07517770 |
| AIDANET x 2 weeks | DEVICE | Approved | Type 1 Diabetes Mellitis | NOT_YET_RECRUITING | NCT07517770 |
| Hybrid Closed Loop (HCL) x 2 weeks | DEVICE | Approved | Type 1 Diabetes Mellitis | NOT_YET_RECRUITING | NCT07517770 |
| SteadiSet Infusion Set | DEVICE | Approved | Diabetes Mellitus, Type 1 | RECRUITING | NCT07325461 |
| t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) | DEVICE | Preclinical | Diabetes Mellitus, Type 1 | RECRUITING | NCT07211126 |
| Automated Insulin Delivery (AID) (usual care) | OTHER | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET in FCL-HCL-mixed mode | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET + HCL | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| AIDANET + FCL | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT07039617 |
| Tight Glycemia Goal | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT07020936 |
| Normal Glycemia Goal | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT07020936 |
| Control-IQ Technology v1.5 | DEVICE | Preclinical | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06717451 |
| AIDANET | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT06633965 |
| t:slim X2 insulin pump with Tandem Freedom Algorithm | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT06834568 |
| SteadiSet Extended Wear Infusion Set | DEVICE | Approved | Type1diabetes | COMPLETED | NCT06273124 |
| SIGI Insulin Management System | DEVICE | Approved | Type 1 Diabetes | NOT_YET_RECRUITING | NCT05973422 |
| Standard Therapy plus continuous glucose monitoring (CGM) | DEVICE | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM | DEVICE | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05785832 |
| t:slim X2 insulin pump with Control-IQ technology 2.0 | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT05683392 |
| CLC + ABC | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| CLC + BAM | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT05610111 |
| t:slim X2 insulin pump with Control-IQ technology 1.5 | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT05422053 |
| Automated Insulin Delivery Settings Initialization and Adaptation Algorithm | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT05204134 |
| Control-IQ technology 1.5 | DEVICE | Approved | Type 2 Diabetes Treated With Insulin | COMPLETED | NCT05111301 |
| Control-IQ technology 2.0 | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT05014789 |
| Control IQ | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04807374 |
| Tandem t:slim X2 with Control-IQ Technology V1.5 | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Standard Care (SC) | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Tandem t:slim X2 with Control-IQ Technology Pro | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04796779 |
| Stable isotope studies- D2 Glucose and D5 Glycerol | PROCEDURE | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Blinded continuous glucose monitor | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Low carbohydrate diet | OTHER | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Continuous glucose monitor | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Insulin pump | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| Stepped hyperinsulinaemic-hypoglycaemic clamp study | PROCEDURE | Approved | Type 1 Diabetes | COMPLETED | NCT04614168 |
| t:slim X2 pump with Control-IQ technology | DEVICE | Preclinical | Diabetes Mellitus, Type 1 | COMPLETED | NCT04503174 |
| Web-based Simulation Tool | OTHER | Approved | Type 1 Diabetes | COMPLETED | NCT04439903 |
| Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring | DEVICE | Approved | Type 1 Diabetes Mellitus With Hypoglycemia | UNKNOWN | NCT04266379 |
| Closed-loop insulin infusion driven by continuous glucose monitoring through an algorithm, in free-life conditions | DEVICE | Approved | Type 1 Diabetes Mellitus With Hypoglycemia | UNKNOWN | NCT04266379 |
| No Empagliflozin + Basal-IQ x 2 wks then Control-IQ x 4 wks | DEVICE | Phase PHASE1 | Type 1 Diabetes | COMPLETED | NCT04201496 |
| No Empagliflozin + Control-IQ x 4 wks then Basal-IQ x 2 wks | DEVICE | Phase PHASE1 | Type 1 Diabetes | COMPLETED | NCT04201496 |
| Control Group | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03844789 |
| Control-IQ with MyTDI | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03804983 |
| Hybrid Closed Loop (HCL) | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03804983 |
| t:slim X2 with Basal-IQ & Dexcom G6 CGM | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03591354 |
| Sensor-augmented pump (SAP) | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03563313 |
| t:slim X2 with Control-IQ Technology & Dexcom G6 CGM | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03844789 |
| Continuous Subcutaneous Insulin Infusion | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Dexcom CGM G5 | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03369067 |
| Tandem t:slim X2 with Control-IQ Technology | DEVICE | Approved | Type1 Diabetes Mellitus | COMPLETED | NCT03368937 |
| Predictive Low Glucose Suspend | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03195140 |
| t:slim insulin pump with predictive low glucose suspend | DEVICE | Phase PHASE1 | Diabetes Mellitus | COMPLETED | NCT02877771 |
| Artificial Pancreas | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02844517 |
| CLC | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02679287 |
Total products: 170